how long have glp 1 agonists been around Navigating the -tides: Medication-Assisted Weight Loss on the Forefront Clinical Focus on GLP-1 Agonists

GLP-1 drugs are quickly becoming some of the most ubiquitous in the U.S., and they have drawn interest for their potential use in treating alcohol use disorder.

Expertly prescribed medications to enhance your weight loss journey.

Preclinical studies suggest that GIPR antagonism helps with weight loss and metabolic improvements

Evidence-based insights for patients and providers.

Some of the dual and triple agonists have already shown initial successes in clinical trials, although the molecular mechanisms underlying their multiplexed pharmacology remain elusive

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore